Any stock, in context
BETA · Healthcare
Beta Drugs Limited
Observation · 15 Oct 2026
How these are readBeta Drugs closed at ₹1,750.3 on 15 Oct 2026, 2.5% above its 200-day average and 20.0% below its 50-day average: above the long line, below the short one. It sits 34.4% below its highest close of the past year, in the middle fifth of its one-year range. Over three months it fell 21.5%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- vs 200-day
- +2.5%
- the long line
- vs 50-day
- −20.0%
- the short line
- From 52w high
- −34.4%
- ₹990.1₹2,807.9
- 3 months
- −21.5%
- sector median −2.7% · 137 of 146
Listed outside the Nifty indices · Healthcare (sector mapped from its industry) · EQ series · median traded value ₹5.76 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- +2.99%
- 1W
- –
- 1M
- −16.86%
- 3M
- −21.48%
- YTD
- –
- 1Y
- +2.27%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.